ReviewDrug design, development and therapy2026
A Comprehensive Review of
Ya Xu, Weijia Xiang, Wanyi Zhu, Lanqi Shang, Mengting Lun, Songyan Qu, Yizhen Yin, Changrong Chen, Honggang Yuan, Yinhong Song
Abstract readReview
In one paragraphReview in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Ya XuHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People's Republic of China.ORCID 0009-0001-0484-9293 Weijia XiangHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People's Republic of China.ORCID 0009-0007-0996-5860 Wanyi ZhuHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People's Republic of China.
Lanqi ShangHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People's Republic of China.
Mengting LunHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People's Republic of China.
Songyan QuHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People's Republic of China.ORCID 0009-0004-7941-6013 Yizhen YinHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People's Republic of China.ORCID 0009-0004-3711-1203 Changrong ChenDepartment of Clinical Laboratory, Affiliated Renhe Hospital of China Three Gorges University, Yichang, People's Republic of China.
Honggang YuanDepartment of Urology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, People's Republic of China.
Yinhong SongHubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People's Republic of China.ORCID 0000-0003-4136-8744 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Hepatocellular carcinoma (HCC) is among the most prevalent malignancies of the digestive system, with a global rising incidence.
Indexed as
Antineoplastic Agents, PhytogenicCarcinoma, HepatocellularDrugs, Chinese HerbalHedyotisLiver NeoplasmsPlant ExtractsScutellariaAnimalsApoptosisCell ProliferationHumansAntineoplastic Agents, PhytogenicDrugs, Chinese HerbalPlant ExtractsHedyotis diffusa Willdhepatocellular carcinomaherb pairScutellaria barbata D. Don
Identifiers
PMID42261445
PMCPMC13242808
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390